|40.35||-1.20 / -2.89%|
As of 3:59pm ET
|40.35||0.00 / 0.00%|
The 3 analysts offering 12-month price forecasts for KYTHERA Biopharmaceuticals Inc have a median target of 50.00, with a high estimate of 56.00 and a low estimate of 41.00. The median estimate represents a +23.92% increase from the last price of 40.35.
The current consensus among 3 polled investment analysts is to Buy stock in KYTHERA Biopharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.